Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health

NCT04293523

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • University Hospital Brno Brno, Czechia
  • University Hospital Ostrava Ostrava, Czechia
  • Dept. of Pediatric Haematology and Oncology, University Hospital Motol Prague, Czechia
  • Lastehaigla, Tallinn (Tallinn Children´s Hospital) Tallinn, Estonia
View all 53 locations
View Trial Details
Active, not recruiting

Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)

NCT03850964

Conditions
Anemia, Cardiovascular Abnormalities, Cardiovascular Diseases, +22 more
Locations
  • University of California - Los Angeles Los Angeles, California, United States
  • University of Colorado Denver, Colorado, United States
  • Augusta University Augusta, Georgia, United States
  • John Hopkins University Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

FT819 in Subjects With B-cell Malignancies

NCT04629729

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Arizona Phoenix, Arizona, United States
  • UC Davis Davis, California, United States
  • Scripps Green Hospital La Jolla, California, United States
View all 18 locations
View Trial Details
Active, not recruiting

Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence

NCT04797000

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Novartis Investigative Site Narita, Chiba, Japan
  • Novartis Investigative Site Kurume, Fukuoka, Japan
  • Novartis Investigative Site Ohtake, Hiroshima, Japan
  • Novartis Investigative Site Nishinomiya, Hyōgo, Japan
View all 20 locations
View Trial Details
Active, not recruiting

A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

NCT05257083

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Arkansas Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health Moores Cancer Center San Diego, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 106 locations
View Trial Details

Related conditions